Quoin Pharmaceuticals receives U.S. patent allowance for Netherton drug

Go back to Quoin Pharmaceuticals receives U.S. patent allowance for Netherton drug
(NASDAQ: QNRX) Delayed: 7.10 +0.20 (2.90%)
Previous Close $6.90    52 Week High
Open $6.98    52 Week Low
Day High $7.16    P/E N/A 
Day Low $6.91    EPS
Volume 23,552